UBS Raises Price Target on Dentsply Int'l (XRAY) to $67; Reiterates Neutral

Go back to UBS Raises Price Target on Dentsply Int'l (XRAY) to $67; Reiterates Neutral

Dentsply Sirona Reports Third Quarter 2016 Results

November 4, 2016 6:30 AM EDT

Reported revenues of $954.2 million, up 47.0% compared to prior year; sales of the combined businesses1 grew 0.4% excluding the effect of exchange ratesGAAP EPS of $0.39, and non-GAAP adjusted EPS of $0.66Closed acquisition of MIS ImplantsAnnounced 5 million share increase in repurchase authorizationRaised bottom end of previous guidance range: adjusted EPS of $2.75 to $2.80

YORK, Pa., Nov. 04, 2016 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona) (NASDAQ: XRAY), The Dental Solutions CompanyTM, today announced its financial results for... More